KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Carlisle Companies (CSL) Research & Development (2016 - 2025)

Carlisle Companies' Research & Development history spans 16 years, with the latest figure at $12.9 million for Q4 2025.

  • For Q4 2025, Research & Development rose 46.59% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $47.1 million, up 33.05%, while the annual FY2025 figure was $47.1 million, 33.05% up from the prior year.
  • Research & Development for Q4 2025 was $12.9 million at Carlisle Companies, up from $12.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $13.8 million in Q2 2021 and bottomed at -$20.6 million in Q4 2021.
  • The 5-year median for Research & Development is $9.8 million (2021), against an average of $7.2 million.
  • The largest annual shift saw Research & Development tumbled 364.1% in 2021 before it skyrocketed 142.11% in 2023.
  • A 5-year view of Research & Development shows it stood at -$20.6 million in 2021, then increased by 7.77% to -$19.0 million in 2022, then surged by 142.11% to $8.0 million in 2023, then increased by 10.0% to $8.8 million in 2024, then surged by 46.59% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for CSL's Research & Development are $12.9 million (Q4 2025), $12.4 million (Q3 2025), and $11.1 million (Q2 2025).